Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ribosomal protein L21 pseudogene 63 (RPL21P63)
- Target
- RPL21P63
- Molecular classification
- Pseudogene
01
Overview
RPL21P63 (ribosomal protein L21 pseudogene 63) belongs to a group of processed pseudogenes derived from the functional ribosomal protein L21 (RPL21) gene, which codes for a component of the large 60S subunit of the ribosome. Unlike protein-coding genes, RPL21P63 is not transcribed into a functional protein and is considered a genomically inactive/degenerated sequence. Housekeeping genes such as RPL21 commonly have many pseudogenes dispersed throughout the genome[2][6]. RPL21P63 does not have an established biological function, does not interact with drugs, and is not recognized as a therapeutic target. Any known disease associations or cellular functions relate to the parent gene RPL21, and not its pseudogenes[1][3][5].
- Other names
- RPL21_24_657RPL21P63
02
Mechanism of action
null
03
Biological functions
Pseudogene (no known expressed function)
04
Disease associations
Other (no known disease association for pseudogene)The functional parent gene RPL21 mutations are linked to hereditary hypotrichosis simplex and hair follicle biology, but this does not apply to pseudogenes[1][3][5]
Beyond the preview
Go deeper on ribosomal protein L21 pseudogene 63 (RPL21P63).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ribosomal protein L21 pseudogene 63 (RPL21P63).